Starpharma Holdings Ltd. (SPHRY)
2.97
0.00 (0.00%)
USD |
OTCM |
Nov 12, 16:00
Starpharma Holdings Market Cap : 128.32M for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 128.32M |
| November 11, 2026 | 128.32M |
| November 10, 2026 | 128.32M |
| November 09, 2026 | 138.48M |
| November 06, 2026 | 138.48M |
| November 05, 2026 | 138.48M |
| November 04, 2026 | 138.48M |
| November 03, 2026 | 135.89M |
| November 02, 2026 | 140.42M |
| October 30, 2026 | 140.42M |
| October 29, 2026 | 151.22M |
| October 28, 2026 | 151.22M |
| October 27, 2026 | 151.22M |
| October 26, 2026 | 151.22M |
| October 23, 2026 | 151.22M |
| October 22, 2026 | 151.22M |
| October 21, 2026 | 151.22M |
| October 20, 2026 | 224.68M |
| October 19, 2026 | 224.68M |
| October 16, 2026 | 224.68M |
| October 15, 2026 | 246.28M |
| October 14, 2026 | 246.28M |
| October 13, 2026 | 246.28M |
| October 12, 2026 | 232.02M |
| October 09, 2026 | 251.68M |
| Date | Value |
|---|---|
| October 08, 2026 | 248.44M |
| October 07, 2026 | 244.12M |
| October 06, 2026 | 244.12M |
| October 05, 2026 | 237.64M |
| October 02, 2026 | 218.20M |
| October 01, 2026 | 252.76M |
| September 30, 2026 | 252.76M |
| September 29, 2026 | 244.21M |
| September 28, 2026 | 246.82M |
| September 25, 2026 | 248.44M |
| September 24, 2026 | 223.81M |
| September 23, 2026 | 235.69M |
| September 22, 2026 | 225.54M |
| September 21, 2026 | 226.40M |
| September 18, 2026 | 239.80M |
| September 17, 2026 | 231.59M |
| September 16, 2026 | 231.59M |
| September 15, 2026 | 218.20M |
| September 14, 2026 | 218.20M |
| September 11, 2026 | 218.20M |
| September 10, 2026 | 231.16M |
| September 09, 2026 | 231.16M |
| September 08, 2026 | 250.60M |
| September 04, 2026 | 224.68M |
| September 03, 2026 | 224.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Percheron Therapeutics Ltd. | 3.654M |
| Neuren Pharmaceuticals Ltd. | 1.744B |
| Mayne Pharma Group Ltd. | 186.05M |
| Acrux Ltd. | 3.137M |
| Zelira Therapeutics Ltd. | 2.433M |
Market Cap Related Metrics
| PS Ratio | 16.10 |
| Price | 2.97 |
| Earnings Yield | -4.13% |